New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

What characteristics make a cancer therapy more likely to effectively treat disease?

How the Maastricht MultiModal Molecular Imaging Institute continues to break new ground in mass spectrometry imaging

Digital technologies could transform healthcare.

Preanalytical variability can be a hidden danger in skewing test results. What's the best way to detect and overcome it?

Artificial intelligence could have a huge impact on drug discovery.

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

Machine learning and DNA methylation could open up a new realm of diagnostic possibility

Testing the whole population of women for breast/ovarian cancers mat be more cost-effective than current methods